These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 19148995)
1. [Using simvastatin in combination with chophytol at early stages of cholelithiasis in elderly patients]. Kobylina EIu; Vakhrushev IaM Eksp Klin Gastroenterol; 2008; (5):11-5. PubMed ID: 19148995 [TBL] [Abstract][Full Text] [Related]
2. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins. Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319 [TBL] [Abstract][Full Text] [Related]
3. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease]. Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581 [TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis]. Vakhrushev IaM; Khokhlacheva NA Eksp Klin Gastroenterol; 2010; (4):105-8. PubMed ID: 20623958 [TBL] [Abstract][Full Text] [Related]
6. [Use of essentiale and cholagogum in prevention of cholelithiasis in fat hepatosis with concomitant cholecystitis]. Vakhrushev IaM; Suchkova EV Ter Arkh; 2005; 77(2):18-21. PubMed ID: 15807444 [TBL] [Abstract][Full Text] [Related]
7. [A clinical research of Naoxinqing tablet's effects on blood fat and viscosity]. Wu XL; Wang MJ; Kuang Y; Zhang WJ; Ao QX Zhong Yao Cai; 2008 Jan; 31(1):171-4. PubMed ID: 18589766 [TBL] [Abstract][Full Text] [Related]
8. [Galstena efficacy in patients with biliary dyskinesia, chronic cholecystitis and cholelithiasis]. Grigor'eva IN; Shabalin AV; Tikhonov AV; Moiseenko EE; Ragino IuI Klin Med (Mosk); 2001; 79(11):52-4. PubMed ID: 11811112 [TBL] [Abstract][Full Text] [Related]
10. [Clinicohemadynamic and biochemical the effect of patients with coronary heart disease use combinated lactoovovegetarian diets and simvastatin]. Medkova IL; Ivanov AN; Mosiakina LI; Biriukova LS Vopr Pitan; 2006; 75(5):49-52. PubMed ID: 17172171 [TBL] [Abstract][Full Text] [Related]
11. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile]. Vakhrushev IaM; Suchkova EV; Khokhlacheva NA Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386 [TBL] [Abstract][Full Text] [Related]
12. The preventive effect of vitamin E on gallstone formation. (3). A study of the biliary lipids in patients with gallstones. Saito T; Tanimura H Nihon Geka Hokan; 1987 May; 56(3):276-88. PubMed ID: 3689084 [No Abstract] [Full Text] [Related]
13. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605 [TBL] [Abstract][Full Text] [Related]
14. [Possibilities of using of crystal-optic qualities of bile in early diagnostic stage of cholelithiasis]. Vakhrushev IaM; Khokhlacheva NA Eksp Klin Gastroenterol; 2011; (4):26-30. PubMed ID: 21916198 [TBL] [Abstract][Full Text] [Related]
15. [Antioxidants in the treatment of cholelithiasis patients]. Vagner EA; Khlebnikov VV; Terekhina NA; Palatova LF Vestn Khir Im I I Grek; 1997; 156(1):36-9. PubMed ID: 9163191 [TBL] [Abstract][Full Text] [Related]
17. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial). Grundy SM; Vega GL; Tomassini JE; Tershakovec AM Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610 [TBL] [Abstract][Full Text] [Related]
18. [Basis for the use of a new galena-based substance from plants for prevention and treatment of cholelithic disease]. Bogdarin IuA; Bundin DV Eksp Klin Gastroenterol; 2003; (3):47-9, 117. PubMed ID: 14556547 [TBL] [Abstract][Full Text] [Related]
19. The impact of residual CVD risk in the managed care setting. Cziraky MJ Am J Manag Care; 2009 Mar; 15(3 Suppl):S74-80. PubMed ID: 19355806 [TBL] [Abstract][Full Text] [Related]
20. [Effect of ursodeoxycholic acid on the characteristics of lipid metabolism in cholelithiasis and gall-bladder cholesterosis]. Il'chenko AA; Drozhzhina IuV Eksp Klin Gastroenterol; 2007; (5):29-34, 164. PubMed ID: 18389594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]